Abstract
Amphibian granular glands provide a wide range of compounds on the skin that defend against pathogens and predators. We identified three bufadienolides—the steroid-like compounds arenobufagin, gamabufotalin, and telocinobufagin—from the boreal toad, Anaxyrus boreas, through liquid chromatography mass spectrometry (LC/MS). Compounds were detected both after inducing skin gland secretions and in constitutive mucosal rinses from toads. We described the antimicrobial properties of each bufadienolide against Batrachochytrium dendrobatidis (Bd), an amphibian fungal pathogen linked with boreal toad population declines. All three bufadienolides were found to inhibit Bd growth at similar levels. The maximum Bd inhibition produced by arenobufagin, gamabufotalin, and telocinobufagin were approximately 50%, in contrast to the complete Bd inhibition shown by antimicrobial skin peptides produced by some amphibian species. In addition, skin mucus samples significantly reduced Bd viability, and bufadienolides were detected in 15 of 62 samples. Bufadienolides also appeared to enhance growth of the anti-Bd bacterium Janthinobacterium lividum, and thus may be involved in regulation of the skin microbiome. Here, we localized skin bacteria within the mucus layer and granular glands of toads with fluorescent in situ hybridization. Overall, our results suggest that bufadienolides can function in antifungal defense on amphibian skin and their production is a potentially convergent trait similar to antimicrobial peptide defenses found on the skin of other species. Further studies investigating bufadienolide expression across toad populations, their regulation, and interactions with other components of the skin mucosome will contribute to understanding the complexities of amphibian immune defense.
Similar content being viewed by others
References
Bletz MC, Loudon AH, Becker MH, Bell SC, Woodhams DC, Minbiole KP, Harris RN (2013) Mitigating amphibian chytridiomycosis with bioaugmentation: characteristics of effective probiotics and strategies for their selection and use. Ecol. Lett. 16:807–820
Harris RN, Brucker RM, Walke JB, Becker MH, Schwantes CR, Flaherty DC, Lam BA, Woodhams DC, Briggs CJ, Vredenburg VT, Minbiole KP (2009) Skin microbes on frogs prevent morbidity and mortality caused by a lethal skin fungus. ISME J 3:818–824. doi:10.1038/ismej.2009.27
Ramsey JP, Reinert LK, Harper LK, Woodhams DC, Rollins-Smith LA (2010) Immune defenses against Batrachochytrium dendrobatidis, a fungus linked to global amphibian declines, in the south African clawed frog, Xenopus laevis. Infect. Immun. 78:3981–3992. doi:10.1128/IAI.00402-10
Woodhams D, Rollins-Smith L, Alford R, Simon M, Harris R (2007) Innate immune defenses of amphibian skin: antimicrobial peptides and more. Anim. Conserv. 10:425–428
Rollins-Smith LA, Doersam JK, Longcore JE, Taylor SK, Shamblin JC, Carey C, Zasloff MA (2002) Antimicrobial peptide defenses against pathogens associated with global amphibian declines. Developmental & Comparative Immunology 26:63–72
Daly JW, Myers CW, Whittaker N (1987) Further classification of skin alkaloids from neotropical poison frogs (Dendrobatidae), with a general survey of toxic/noxious substances in the amphibia. Toxicon 25:1023–1095
Clarke BT (1997) The natural history of amphibian skin secretions, their normal functioning and potential medical applications. Biol. Rev. 72:365–379. doi:10.1017/S0006323197005045
Rd T, Jared C (1995) Cutaneous granular glands and amphibian venoms. Comp. Biochem. Physiol. A Physiol. 111:1–29
Jared C, Antoniazzi MM, Jordao AE, Silva JRM, Greven H, Rodrigues MT (2009) Parotoid macroglands in toad (Rhinella jimi): their structure and functioning in passive defence. Toxicon 54:197–207
Krenn L, Kopp B (1998) Bufadienolides from animal and plant sources. Phytochemistry 48:1–29
Cunha Filho GA, Schwartz CA, Resck IS, Murta MM, Lemos SS, Castro MS, Kyaw C, Pires OR, Leite JRS, Bloch C (2005) Antimicrobial activity of the bufadienolides marinobufagin and telocinobufagin isolated as major components from skin secretion of the toad Bufo rubescens. Toxicon 45:777–782
Woodhams DC, Voyles J, Lips KR, Carey C, Rollins-Smith LA (2006) Predicted disease susceptibility in a Panamanian amphibian assemblage based on skin peptide defenses. J. Wildl. Dis. 42:207–218. doi:10.7589/0090-3558-42.2.207
Garg AD, Hippargi RV, Gandhare AN (2008) Toad skin-secretions: potent source of pharmacologically and therapeutically significant compounds. The Internet Journal of Pharmacology 5:17
Noble GK (1931) The biology of the amphibia. McGraw-Hill, New York
Preusser HJ, Habermehl G, Sablofski M, Schmall-Haury D (1975) Antimicrobial activity of alkaloids from amphibian venoms and effects on the ultrastructure of yeast cells. Toxicon 13:285–289
Berger L, Speare R, Daszak P, Green DE, Cunningham AA, Goggin CL, Slocombe R, Ragan MA, Hyatt AD, McDonald KR, Hines HB, Lips KR, Marantelli G, Parkes H (1998) Chytridiomycosis causes amphibian mortality associated with population declines in the rain forests of Australia and central America. Proc. Natl. Acad. Sci. U. S. A. 95:9031–9036
Longcore JE, Pessier AP, Nichols DK (1999) Batrachochytrium Dendrobatidis gen. et sp. nov., a Chytrid pathogenic to amphibians. Mycologia 91:219. doi:10.2307/3761366
Fisher MC, Garner TW, Walker SF (2009) Global emergence of Batrachochytrium dendrobatidis and amphibian chytridiomycosis in space, time, and host. Annu. Rev. Microbiol. 63:291–310. doi:10.1146/annurev.micro.091208.073435
James TY, Kauff F, Schoch CL, Matheny PB, Hofstetter V, Cox CJ, Celio G, Gueidan C, Fraker E, Miadlikowska J (2006) Reconstructing the early evolution of fungi using a six-gene phylogeny. Nature 443:818–822
Van Rooij P, Martel A, Haesebrouck F, Pasmans F (2015) Amphibian chytridiomycosis: a review with focus on fungus-host interactions. Vet. Res. 46:137. doi:10.1186/s13567-015-0266-0
Hanlon SM, Lynch KJ, Kerby J, Parris MJ (2015) Batrachochytrium dendrobatidis exposure effects on foraging efficiencies and body size in anuran tadpoles. Dis. Aquat. Org. 112:237–242. doi:10.3354/dao02810
Campbell CR, Voyles J, Cook DI, Dinudom A (2012) Frog skin epithelium: electrolyte transport and chytridiomycosis. Int. J. Biochem. Cell Biol. 44:431–434. doi:10.1016/j.biocel.2011.12.002
Searle CL, Gervasi SS, Hua J, Hammond JI, Relyea RA, Olson DH, Blaustein AR (2011) Differential host susceptibility to Batrachochytrium dendrobatidis, an emerging amphibian pathogen. Conserv. Biol. 25:965–974. doi:10.1111/j.1523-1739.2011.01708.x
Stuart SN, Chanson JS, Cox NA, Young BE, Rodrigues AS, Fischman DL, Waller RW (2004) Status and trends of amphibian declines and extinctions worldwide. Science 306:1783–1786. doi:10.1126/science.1103538
IUCN (2015) The IUCN red list of threatened species. http://www.iucnredlist.org. Accessed 27 Nov 2015
Pilliod DS, Muths E, Scherer RD, Bartelt PE, Corn PS, Hossack BR, Lambert BA, McCaffery R, Gaughan C (2010) Effects of amphibian chytrid fungus on individual survival probability in wild boreal toads. Conserv. Biol. 24:1259–1267. doi:10.1111/j.1523-1739.2010.01506.x
Skerratt LF, Berger L, Speare R, Cashins S, McDonald KR, Phillott AD, Hines HB, Kenyon N (2007) Spread of chytridiomycosis has caused the rapid global decline and extinction of frogs. EcoHealth 4:125–134
Weldon C, du Preez LH, Hyatt AD, Muller R, Spears R (2004) Origin of the amphibian chytrid fungus. Emerg. Infect. Dis. 10:2100–2105. doi:10.3201/eid1012.030804
Daszak P, Strieby A, Cunningham AA, Longcore J, Brown C, Porter D (2004) Experimental evidence that the bullfrog (Rana catesbeiana) is a potential carrier of chytridiomycosis, an emerging fungal disease of amphibians. Herpetol. J. 14:201–207
Peterson AC, McKenzie VJ (2014) Investigating differences across host species and scales to explain the distribution of the amphibian pathogen Batrachochytrium dendrobatidis. PLoS One 9:e107441. doi:10.1371/journal.pone.0107441
La Marca E, Lips KR, Lötters S, Puschendorf R, Ibáñez R, Rueda-Almonacid JV, Schulte R, Marty C, Castro F, Manzanilla-Puppo J (2005) Catastrophic population declines and extinctions in Neotropical harlequin frogs (Bufonidae: Atelopus) 1. Biotropica 37:190–201
Ellison AR, Savage AE, DiRenzo GV, Langhammer P, Lips KR, Zamudio KR (2014) Fighting a losing battle: vigorous immune response countered by pathogen suppression of host defenses in the chytridiomycosis-susceptible frog Atelopus zeteki. G3 (Bethesda) 4:1275–1289. doi:10.1534/g3.114.010744
Hunter DA, Speare R, Marantelli G, Mendez D, Pietsch R, Osborne W (2010) Presence of the amphibian chytrid fungus Batrachochytrium dendrobatidis in threatened corroboree frog populations in the Australian alps. Dis. Aquat. Org. 92:209–216
James TY, Toledo LF, Rodder D, da Silva LD, Belasen AM, Betancourt-Roman CM, Jenkinson TS, Soto-Azat C, Lambertini C, Longo AV, Ruggeri J, Collins JP, Burrowes PA, Lips KR, Zamudio KR, Longcore JE (2015) Disentangling host, pathogen, and environmental determinants of a recently emerged wildlife disease: lessons from the first 15 years of amphibian chytridiomycosis research. Ecology and Evolution 5:4079–4097. doi:10.1002/ece3.1672
Anderson R, May R, Joysey K, Mollison D, Conway G, Cartwell R, Thompson H, Dixon B (1986) The invasion, persistence and spread of infectious diseases within animal and plant communities [and discussion]. Philosophical Transactions of the Royal Society B: Biological Sciences 314:533–570
Murphy PJ, St-Hilaire S, Bruer S, Corn PS, Peterson CR (2009) Distribution and pathogenicity of Batrachochytrium dendrobatidis in boreal toads from the grand Teton area of western Wyoming. EcoHealth 6:109–120. doi:10.1007/s10393-009-0230-4
Goebel AM, Ranker TA, Corn PS, Olmstead RG (2009) Mitochondrial DNA evolution in the Anaxyrus boreas species group. Mol. Phylogenet. Evol. 50:209–225. doi:10.1016/j.ympev.2008.06.019
Rollins-Smith LA, Reinert LK, O’Leary CJ, Houston LE, Woodhams DC (2005) Antimicrobial peptide defenses in amphibian skin. Integr. Comp. Biol. 45:137–142
Umile TP, McLaughlin PJ, Johnson KR, Honarvar S, Blackman AL, Burzynski EA, Davis RW, Teotonio TL, Hearn GW, Hughey CA, Lagalante AF, Minbiole KPC (2014) Nonlethal amphibian skin swabbing of cutaneous natural products for HPLC fingerprinting. Anal. Methods 6:3277–3284. doi:10.1039/c4ay00566j
Lowrey L, Woodhams DC, Tacchi L, Salinas I (2015) Topographical mapping of the rainbow trout (Oncorhynchus mykiss) microbiome reveals a diverse bacterial community with antifungal properties in the skin. Appl. Environ. Microbiol. 81:6915–6925
Woodhams DC, Brandt H, Baumgartner S, Kielgast J, Kupfer E, Tobler U, Davis LR, Schmidt BR, Bel C, Hodel S, Knight R, McKenzie V (2014) Interacting symbionts and immunity in the amphibian skin mucosome predict disease risk and probiotic effectiveness. PLoS One 9:e96375. doi:10.1371/journal.pone.0096375
Pask JD, Woodhams DC, Rollins-Smith LA (2012) The ebb and flow of antimicrobial skin peptides defends northern leopard frogs (Rana pipiens) against chytridiomycosis. Glob. Chang. Biol. 18:1231–1238
Ogata K, Nishikawa H, Ohsugi M (1969) A yeast capable of utilizing methanol. Agric. Biol. Chem. 33:1519–1520
Brunetti AE, Merib J, Carasek E, Caramão EB, Barbará J, Zini CA, Faivovich J (2015) Frog volatile compounds: application of in vivo SPME for the characterization of the odorous secretions from two species of hypsiboas treefrogs. J. Chem. Ecol. 41:360–372
Grice EA, Segre JA (2011) The skin microbiome. Nat. Rev. Microbiol. 9:244–253. doi:10.1038/nrmicro2537
Bataille A, Lee-Cruz L, Tripathi B, Kim H, Waldman B (2016) Microbiome variation across amphibian skin regions: implications for chytridiomycosis mitigation efforts. Microb. Ecol. 71:221–232. doi:10.1007/s00248-015-0653-0
Hayes RA, Piggott AM, Dalle K, Capon RJ (2009) Microbial biotransformation as a source of chemical diversity in cane toad steroid toxins. Bioorg. Med. Chem. Lett. 19:1790–1792
Rollins-Smith LA, Conlon JM (2005) Antimicrobial peptide defenses against chytridiomycosis, an emerging infectious disease of amphibian populations. Developmental & Comparative Immunology 29:589–598. doi:10.1016/j.dci.2004.11.004
Conlon JM (2011) The contribution of skin antimicrobial peptides to the system of innate immunity in anurans. Cell Tissue Res. 343:201–212. doi:10.1007/s00441-010-1014-4
Pédron T, Mulet C, Dauga C, Frangeul L, Chervaux C, Grompone G, Sansonetti PJ (2012) A crypt-specific core microbiota resides in the mouse colon. MBio 3:e00116–e00112
Marr AK, Gooderham WJ, Hancock RE (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6:468–472
Bahar AA, Ren D (2013) Antimicrobial peptides. Pharmaceuticals (Basel) 6:1543–1575. doi:10.3390/ph6121543
Brogden NK, Brogden KA (2011) Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int. J. Antimicrob. Agents 38:217–225
Steinstraesser L, Kraneburg U, Jacobsen F, Al-Benna S (2011) Host defense peptides and their antimicrobial-immunomodulatory duality. Immunobiology 216:322–333
Yamahara J, Tanaka S, Matsuda H, Sawada T, Fujimura H (1986) The mode of cardiac action of cardiotonic steroids isolated from toad cake in perfused working guinea-pig heart and effect of cinobufagin on experimental heart failure. Nihon Yakurigaku Zasshi 88:413–423
Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, Ye WC (2013) Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Carcinogenesis 34:1331–1342. doi:10.1093/carcin/bgt060
Nogawa T, Kamano Y, Yamashita A, Pettit GR (2001) Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch’an Su. J. Nat. Prod. 64:1148–1152
Matsukawa M, Akizawa T, Ohigashi M, Morris JF, Butler Jr VP, Yoshioka M (1997) A novel bufadienolide, marinosin, in the skin of the giant toad, Bufo marinus. Chemical and Pharmaceutical Bulletin (Tokyo) 45:249–254
Hirai Y, Morishita S, Ito C, Sakanashi M (1992) Effects of bufadienolides and some kinds of cardiotonics on guinea-pig hearts. Folia Pharmacologica Japonica 100:127–135
Briggs CJ, Knapp RA, Vredenburg VT (2010) Enzootic and epizootic dynamics of the chytrid fungal pathogen of amphibians. Proc. Natl. Acad. Sci. U. S. A. 107:9695–9700. doi:10.1073/pnas.0912886107
Holden WM, Reinert LK, Hanlon SM, Parris MJ, Rollins-Smith LA (2015) Development of antimicrobial peptide defenses of southern leopard frogs, Rana sphenocephala, against the pathogenic chytrid fungus, Batrachochytrium dendrobatidis. Developmental & Comparative Immunology 48:65–75. doi:10.1016/j.dci.2014.09.003
Woodhams DC, Bell SC, Bigler L, Caprioli RM, Chaurand P, Lam BA, Reinert LK, Stalder U, Vazquez VM, Schliep K, Hertz A, Rollins-Smith LA (2016) Life history linked to immune investment in developing amphibians. Conservation Physiology 4:cow025. doi:10.1093/conphys/cow025
Benard MF, Fordyce JA (2003) Are induced defenses costly? Consequences of predator-induced defenses in western toads, Bufo boreas. Ecology 84:68–78
Garner T, Garcia G, Carroll B, Fisher M (2009) Using itraconazole to clear Batrachochytrium dendrobatidis infection, and subsequent depigmentation of Alytes muletensis tadpoles. Dis. Aquat. Org. 83:257–260
Woodhams DC, Geiger CC, Reinert LK, Rollins-Smith LA, Lam B, Harris RN, Briggs CJ, Vredenburg VT, Voyles J (2012) Treatment of amphibians infected with chytrid fungus: learning from failed trials with itraconazole, antimicrobial peptides, bacteria, and heat therapy. Dis. Aquat. Org. 98:11–25. doi:10.3354/dao02429
Berger L, Speare R, Pessier A, Voyles J, Skerratt LF (2010) Treatment of chytridiomycosis requires urgent clinical trials. Dis. Aquat. Org. 92:165–174. doi:10.3354/dao02238
Woodhams DC, Alford RA, Marantelli G (2003) Emerging disease of amphibians cured by elevated body temperature. Dis. Aquat. Org. 55:65–67. doi:10.3354/dao055065
Woodhams D, Ardipradja K, Alford R, Marantelli G, Reinert L, Rollins-Smith L (2007) Resistance to chytridiomycosis varies among amphibian species and is correlated with skin peptide defenses. Anim. Conserv. 10:409–417
White A (2006) A trial using salt to protect green and golden bell frogs from chytrid infection. HERPETOFAUNA-SYDNEY- 36: 93.
Woodhams DC, Vredenburg VT, Simon M-A, Billheimer D, Shakhtour B, Shyr Y, Briggs CJ, Rollins-Smith LA, Harris RN (2007) Symbiotic bacteria contribute to innate immune defenses of the threatened mountain yellow-legged frog, Rana muscosa. Biol. Conserv. 138:390–398
Kueneman JG, Woodhams DC, Harris R, Archer HM, Knight R, McKenzie VJ (2016) Probiotic treatment restores protection against lethal fungal infection lost during amphibian captivity. Proceedings of the Royal Society B, Vol. 283. No 1839, pp. 20161553. The Royal Society
Becker MH, Walke JB, Cikanek S, Savage AE, Mattheus N, Santiago CN, Minbiole KP, Harris RN, Belden LK, Gratwicke B (2015) Composition of symbiotic bacteria predicts survival in Panamanian golden frogs infected with a lethal fungus. Proc. R. Soc. B 282:20142881. doi:10.1098/rspb.2014.2881
Küng D, Bigler L, Davis LR, Gratwicke B, Griffith E, Woodhams DC (2014) Stability of microbiota facilitated by host immune regulation: informing probiotic strategies to manage amphibian disease. PLoS One 9:e87101. doi:10.1371/journal.pone.0087101
Kueneman JG, Woodhams DC, Van Treuren W, Archer HM, Knight R, McKenzie VJ (2016) Inhibitory bacteria reduce fungi on early life stages of endangered Colorado boreal toads (Anaxyrus boreas). ISME J 10:934–944
Kueneman JG, Parfrey LW, Woodhams DC, Archer HM, Knight R, McKenzie VJ (2014) The amphibian skin-associated microbiome across species, space and life history stages. Mol. Ecol. 23:1238–1250. doi:10.1111/mec.12510
Savage AE, Zamudio KR (2016) Adaptive tolerance to a pathogenic fungus drives major histocompatibility complex evolution in natural amphibian populations. Proceedings of the Royal Society B Vol. 283. No 1827. The Royal Society
Myers JM, Ramsey JP, Blackman AL, Nichols AE, Minbiole KP, Harris RN (2012) Synergistic inhibition of the lethal fungal pathogen Batrachochytrium dendrobatidis: the combined effect of symbiotic bacterial metabolites and antimicrobial peptides of the frog Rana muscosa. J. Chem. Ecol. 38:958–965. doi:10.1007/s10886-012-0170-2
Loudon AH, Holland JA, Umile TP, Burzynski EA, Minbiole KPC, Harris RN (2014) Interactions between amphibians’ symbiotic bacteria cause the production of emergent anti-fungal metabolites. Front. Microbiol. 5:441. doi:10.3389/fmicb.2014.00441
Berger L, Marantelli G, Skerratt LL, Speare R (2005) Virulence of the amphibian chytrid fungus Batrachochytrium dendrobatidis varies with the strain. Dis. Aquat. Org. 68:47–50. doi:10.3354/dao068047
Olson DH, Aanensen DM, Ronnenberg KL, Powell CI, Walker SF, Bielby J, Garner TW, Weaver G, Bd Mapping G, Fisher MC (2013) Mapping the global emergence of Batrachochytrium dendrobatidis, the amphibian chytrid fungus. PLoS One 8:e56802. doi:10.1371/journal.pone.0056802
Berger L, Speare R, Hines H, Marantelli G, Hyatt A, McDonald K, Skerratt L, Olsen V, Clarke J, Gillespie G (2004) Effect of season and temperature on mortality in amphibians due to chytridiomycosis. Aust. Vet. J. 82:82
Gervasi S, Gondhalekar C, Olson DH, Blaustein AR (2013) Host identity matters in the amphibian-Batrachochytrium dendrobatidis system: fine-scale patterns of variation in responses to a multi-host pathogen. PLoS One 8:e54490. doi:10.1371/journal.pone.0054490
Becker MH, Harris RN (2010) Cutaneous bacteria of the redback salamander prevent morbidity associated with a lethal disease. PLoS One 5:e10957. doi:10.1371/journal.pone.0010957
Richards-Zawacki CL (2010) Thermoregulatory behaviour affects prevalence of chytrid fungal infection in a wild population of Panamanian golden frogs. Proc. R. Soc. B 277:519–528. doi:10.1098/rspb.2009.1656
Acknowledgements
The authors thank Brandon LaBumbard and Bhumi Patel for their technical assistance. This study was funded in part by an NSF grant (DEB-1146284) to VJM and the Dimensions in Biodiversity program DEB-1136662 to KPCM.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Barnhart, K., Forman, M.E., Umile, T.P. et al. Identification of Bufadienolides from the Boreal Toad, Anaxyrus boreas, Active Against a Fungal Pathogen. Microb Ecol 74, 990–1000 (2017). https://doi.org/10.1007/s00248-017-0997-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00248-017-0997-8